等待开盘 05-19 09:30:00 美东时间
-0.220
-7.51%
Kala Bio (NASDAQ:KALA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.30) by 53.33 percent. This is a 99.8 percent increase over losses of $(70.49) per share from the same
05-16 07:12
KALA BIO shares are trading lower after the company announced a 1-for-50 revers...
05-07 21:24
KALA BIO, Inc. (NASDAQ: KALA) ("KALA BIO" or the "Company"), today announced that it intends to effect a reverse stock split of its common stock, par value $0.001 per share (the "common stock") at a ratio of 1 post-split
05-07 21:03
Kala Bio (NASDAQ:KALA) reported quarterly earnings of $0.86 per share which beat the analyst consensus estimate of $(1.44) by 159.72 percent. This is a 149.43 percent increase over losses of $(1.74) per share from the
04-16 05:26
Undervalued companies in health care sector with low RSI values present buying opportunity: PepGen Inc (PEPG), KALA BIO Inc (KALA), Viridian Therapeutics Inc (VRDN)
04-08 18:40
The Bionic Intelligence Research Agent is a fully autonomous AI research specialist built for the biotechnology and pharmaceutical sectors
03-30 20:32
Kala Bio launches BIRA AI agent for biotech research, marking a shift to commercial deployment and a potential recurring revenue model.
03-30 20:31
OCUGEN飙升近30%,机构首次覆盖该公司并给予高额目标价;纳微半导体大涨近25%,推出适用于人工智能数据中心的两款新产品>>
03-12 16:40
Is KALA the Palantir of biotech? Kala Bio Inc. pivots to agentic AI with a new platform shipping in 2 weeks. Read the full update.
03-11 20:08
Gainers Can Fite Biopharma (AMEX:CANF) stock rose 17.6% to $5.88 during Wednes...
03-04 20:05